Reliance on Clinical Signs and Symptoms Assessment Leads to Misuse of Antimicrobials: Post hoc Analysis of 350 Chronic Wounds

Thomas E Serena, Lisa Gould, Karen Ousey, Robert S Kirsner, Thomas E Serena, Lisa Gould, Karen Ousey, Robert S Kirsner

Abstract

Objectives: Bacteria frequently impede wound healing and cause infection. Clinicians rely on clinical signs and symptoms (CSS) to assess for bacteria at the point of care, and inform prescription of antibiotics and other antimicrobials. Yet, robust evidence suggests that CSS has poor sensitivity for detection of problematic bacterial burden and infection, hindering antimicrobial stewardship efforts. This study evaluated CSS-based antimicrobial prescribing practices across 14 wound care centers. Approach: Data were analyzed from the fluorescence assessment and guidance (FLAAG) trial, a study of 350 chronic wounds across 20 clinicians. Clinicians reviewed patient history and assessed for CSS using the International Wound Infection Institute infection checklist. Wounds with >3 criteria or any overwhelming symptom were considered CSS+. Bacterial levels were confirmed with quantitative tissue culture of wound biopsies. Results: Antimicrobials (including dressings, topicals, and systemic antibiotics) were prescribed at a similar rate for wounds identified as CSS+ (75.0%) and CSS- (72.8%, p = 0.76). Antimicrobial dressings, the most frequently prescribed antimicrobial, were prescribed at a similar rate for CSS+ (83.3%) and CSS- (89.5%, p = 0.27) wounds. In 33.3% of patients prescribed systemic antibiotics, no CSS were present. Prescribing patterns did not correlate with bacterial load. Innovation: This study is the first to evaluate antimicrobial prescribing trends in a large, multisite cohort of chronic wound patients. Conclusions: Reliance on CSS to diagnose clinically significant bacterial burden in chronic wounds leads to the haphazard use of antimicrobials. Improved methods of identifying bacterial burden and infection are needed to enhance antimicrobial stewardship efforts in wound care. Clinicaltrials.gov ID. NCT03540004.

Keywords: antibiotic prescribing; antimicrobial stewardship; bacterial burden; chronic wounds; clinical decision support; diagnostic pathway; wound clinic.

Conflict of interest statement

The authors declare no financial interests or conflicts of interest to disclose.

Figures

https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9527054/bin/wound.2021.0146_figure4.jpg
Thomas E. Serena, MD
Figure 1.
Figure 1.
Total bacterial load of study wounds identified as negative (CSS−) or positive (CSS+) for CSS based on International Wound Infection Institute (IWII) wound infection criteria. Box and whisker plot of total bacterial load for wounds deemed CSS− (n = 302) and CSS+ (n = 48). Open circles represent individual study wounds; middle lines indicate median bacterial load; error bars indicate range. Of the CSS− wounds, 36 had total bacterial load of 0. Dashed lines at 104 CFU/g represent minimum bacterial threshold at which delayed healing is observed; dashed lines at 105 CFU/g and 106 CFU/g represent minimum bacterial thresholds at which wounds are considered infected and treatment is warranted. ***p < 0.001 by the Mann–Whitney test of log-transformed data. CSS, clinical signs and symptoms; CFU, colony forming units.
Figure 2.
Figure 2.
Antimicrobial (a) and antibiotic (b) prescription based on assessment of CSS, patient history, and clinical judgment. Antimicrobials included topicals, dressings and antibiotics (topical or systemic), antibiotics included topicals, oral or intravenous. Percentages reflect proportion of CSS+ and CSS− wounds among all participants (n = 350), participants with bacterial loads of <104 CFU/g (n = 63), and participants with >108 CFU/g (n = 44). p values derived from chi-square tests after correcting for multiple comparisons. Any comparisons for which p-values are not shown were not significant.
Figure 3.
Figure 3.
(a) Types of antimicrobials prescribed based on patient history and visual assessment of CSS of infection. Wounds with three or more CSS based on IWII criteria were considered positive for CSS (CSS+). Frequency represents the proportion out of the total number of antimicrobials prescribed for either CSS+ or CSS− wounds. (b) Frequency of specific CSS detected in patients prescribed systemic (oral or intravenous) antibiotics. Values represent % of all patients prescribed systemic antibiotics. Covert, overt, and spreading represent the designated categories of CSS in the IWII guidelines. p values derived from chi-square tests after correcting for multiple comparisons.
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9527054/bin/wound.2021.0146_figure5.jpg

References

    1. Fife CE, Eckert KA, Carter MJ. Publicly reported wound healing rates: the fantasy and the reality. Adv Wound Care (New Rochelle) 2018;7:77–94.
    1. Frykberg RG, Banks J. Challenges in the treatment of chronic wounds. Adv Wound Care 2015;4:560–582.
    1. Lantis JC, 2nd, Marston WA, Farber A, et al. . The influence of patient and wound variables on healing of venous leg ulcers in a randomized controlled trial of growth-arrested allogeneic keratinocytes and fibroblasts. J Vasc Surg 2013;58:433–439.
    1. Robson MC, Heggers JP. Delayed wound closure based on bacterial counts. J Surg Oncol 1970;2:379–383.
    1. Xu L, McLennan SV, Lo L, et al. . Bacterial load predicts healing rate in neuropathic diabetic foot ulcers. Diabetes Care 2007;30:378–380.
    1. Davies CE, Hill KE, Newcombe RG, et al. . A prospective study of the microbiology of chronic venous leg ulcers to reevaluate the clinical predictive value of tissue biopsies and swabs. Wound Repair Regen 2007;15:17–22.
    1. Lipsky BA, Berendt AR, Cornia PB, et al. . 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012;54:e132–e173.
    1. Schultz GS, Sibbald RG, Falanga V, et al. . Wound bed preparation: a systematic approach to wound management. Wound Repair Regen 2003;11(Suppl 1):S1–S28.
    1. FDA. Battle of the bugs: fighting antibiotic resistance. 2016. (last accessed July 2021).
    1. Howell-Jones RS, Wilson MJ, Hill KE, Howard AJ, Price PE, Thomas DW. A review of the microbiology, antibiotic usage and resistance in chronic skin wounds. J Antimicrob Chemother 2005;55:143–149.
    1. Dolk FCK, Pouwels KB, Smith DRM, Robotham JV, Smieszek T. Antibiotics in primary care in England: which antibiotics are prescribed and for which conditions? J Antimicrob Chemother 2018;73(Suppl_2):ii2-ii10.
    1. Lipsky BA, Dryden M, Gottrup F, Nathwani D, Seaton RA, Stryja J. Antimicrobial stewardship in wound care: a Position Paper from the British Society for Antimicrobial Chemotherapy and European Wound Management Association. J Antimicrob Chemother 2016;71:3026–3035.
    1. Edmonds M. Body of knowledge around the diabetic foot and limb salvage. J Cardiovasc Surg 2012;53:605–616.
    1. Le L BM, Briggs P, Bullock N, et al. . Diagnostic Accuracy of Point-of-Care Fluorescence Imaging for the Detection of Bacterial Burden in Wounds: results from the 350-Patient Fluorescence Imaging Assessment and Guidance Trial. Adv Wound Care 2021;10:123–136.
    1. Serena TE, Harrell K, Serena L, Yaakov RA. Real-time bacterial fluorescence imaging accurately identifies wounds with moderate-to-heavy bacterial burden. J Wound Care 2019;28:346–357.
    1. Gardner SE, Frantz RA, Doebbeling BN. The validity of the clinical signs and symptoms used to identify localized chronic wound infection. Wound Repair Regen 2001;9:178–186.
    1. Gardner SE, Hillis SL, Frantz RA. Clinical signs of infection in diabetic foot ulcers with high microbial load. Biol Res Nurs 2009;11:119–128.
    1. Gardner SE, Frantz RA, Troia C, et al. . A tool to assess clinical signs and symptoms of localized infection in chronic wounds: development and reliability. Ostomy Wound Manage 2001;47:40–47.
    1. Reddy M, Gill SS, Wu W, Kalkar SR, Rochon PA. Does this patient have an infection of a chronic wound? JAMA 2012;307:605–611.
    1. Organization WH. Global Action Plan on Antimicrobial Resistance, 2015. (last accessed July 2021).
    1. The Joint Commission. R3 Report Issue 8: New Antimicrobial Stewardship Standard. (last accessed July 2021).
    1. Serena TE. Incorporating Point-of-Care Bacterial Fluorescence into a Wound Clinic Antimicrobial Stewardship Program. Diagnostics (Basel) 26 2020;10.
    1. Le L, Baer M, Briggs P, et al. . Diagnostic Accuracy of Point-of-Care Fluorescence Imaging for the Detection of Bacterial Burden in Wounds: results from the 350-Patient Fluorescence Imaging Assessment and Guidance Trial. Adv Wound Care (New Rochelle) 2021;10:123–136.
    1. International Wound Infection Institute (IWII). Wound infection in clinical practice. London, UK: Wounds International, 2016.
    1. Serena TE, Bowler PG, Schultz GS, D'souza A, Rennie MY. Are Semi-Quantitative Clinical Cultures Inadequate? Comparison to Quantitative Analysis of 1053 Bacterial Isolates from 350 Wounds. Diagnostics 2021;11:1239.
    1. Sibbald RG, Browne AC, Coutts P, Queen D. Screening evaluation of an ionized nanocrystalline silver dressing in chronic wound care. Ostomy Wound Manage 2001;47:38–43.
    1. Caldwell MD. Bacteria and antibiotics in wound healing. Surg Clin North Am 2020;100:757–776.
    1. Gardner SE, Frantz RA, Park H, Scherubel M. The inter-rater reliability of the Clinical Signs and Symptoms Checklist in diabetic foot ulcers. Ostomy Wound Manage 2007;53:46–51.
    1. Sibbald RG, Coutts P, Woo KY. Reduction of bacterial burden and pain in chronic wounds using a new polyhexamethylene biguanide antimicrobial foam dressing-clinical trial results. Adv Skin Wound Care 2011;24:78–84.
    1. LantisII JC, Gendics C. In vivo effect of sustained-release silver sulphadiazine foam on bioburden and wound closure in infected venous leg ulcers. J Wound Care 2011;20:90–96.
    1. Bhattacharya S. Wound healing through the ages. Indian J Plast Surg 2012;45:177–179.
    1. Lipsky BA, Senneville E, Abbas ZG, et al. . Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev 2020;36(Suppl 1):e3280.
    1. Guest JF, Fuller GW, Vowden P. Diabetic foot ulcer management in clinical practice in the UK: costs and outcomes. Int Wound J 2018;15:43–52.
    1. Halpern NJL, Ravitz RJ. Malpractice Liability Considerations for Wound Clinics. Today's Wound Clinic 2017. .
    1. Hurley HJ, Knepper BC, Price CS, Mehler PS, Burman WJ, Jenkins TC. Avoidable antibiotic exposure for uncomplicated skin and soft tissue infections in the ambulatory care setting. Am J Med 2013;126:1099–1106.
    1. Tamma PD, Avdic E, Li DX, Dzintars K, Cosgrove SE. Association of Adverse Events With Antibiotic Use in Hospitalized Patients. JAMA Intern Med 2017;177:1308–1315.
    1. Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf 2014;5:229–241.
    1. Serena TE, Cullen BM, Bayliff SW, et al. . Defining a new diagnostic assessment parameter for wound care: elevated protease activity, an indicator of nonhealing, for targeted protease-modulating treatment. Wound Repair Regen 2016;24:589–595.
    1. Thet NT, Mercer-Chalmers J, Greenwood RJ, et al. . SPaCE Swab: point-of-Care sensor for simple and rapid detection of acute wound infection. ACS Sensors 2020;5:2652–2657.
    1. Oropallo AR, Andersen C, Abdo R, et al. . Guidelines for point-of-care fluorescence imaging for detection of wound bacterial burden based on delphi consensus. Diagnostics 2021;11:1219.
    1. Price N. Routine fluorescence imaging to detect wound bacteria reduces antibiotic use and antimicrobial dressing expenditure while improving healing rates: retrospective analysis of 229 foot ulcers. Diagnostics 2020;10:927.
    1. Kavic MS. The US medical liability system—a system in crisis. JSLS 2004;8:1–2.

Source: PubMed

3
Předplatit